HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus

Journal of Leukocyte Biology

Volumn 78, Issue 3, 2005, Pages 675-685

  Brown, Amanda ^a,b   Gartner, Suzanne ^a   Kawano, Thomas ^b   Benoit, Nicole ^a   Cheng Mayer, Cecilia ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Confocal microscopy; Immunofluorescence; MHC; Nef

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; PROLINE;

ANTIGEN EXPRESSION; ARTICLE; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REPORTER GENE; T LYMPHOCYTE; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE;

ANTIGENS, CD4; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE PRODUCTS, NEF; GREEN FLUORESCENT PROTEINS; HIV-1; HLA-A2 ANTIGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; T-LYMPHOCYTES; TIME FACTORS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 24744465855     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0505237     Document Type: Article

References (99)

1. Gartner, S., Markovits, P., Markovits, D. M., Kaplan, M. H., Gallo, K. C., Popovic, M. (1986) The role of mononuclear phagocytes in HTLV-III/ LAV infection. Science 233, 215-2l9〈/jrn〉.
2. Ho, D. D., Rota, T. R., Hirsch, M. S. (1986) Infection of monocyte/ macrophages by human T lymphotrophic virus type III. J. Clin. Invest. 77, 1712-1715.
3. Meltzer, M. S., Nakamura, M., Hansen, B. D., Turpin, J. A., Kalter, D. C., Gendelman, H. E. (1990) Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res. Hum. Retroviruses 6, 967-971.
4. Connor, R. I., Sheridan, K. E., Lai, C., Zhang, L., Ho, D. D. (1996) Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type I infection. J. Virol. 70, 5306-5311.
5. Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., de Goede, R. E., van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F., Tersmette, M. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus. J. Virol. 66, 1354-1360.
6. van't Wout, A. B., Kootstra, N. A., Mulder-Kampinga, G. A., Albrecht-van Lent, N., Scherpbier, H. J., Veenstra, J., Boer, K., Coutinho, R. A., Miedema, F., Schuitemaker, H. (1994) Macrophage-tropic variants initiate human immunodeficiency virus type I infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94, 2060-2067.
7. Shaw, G., Harper, M. E., Hahn, B., Epstein, L. G., Gajdusek, D. C., Price, R. W., Navia, K. A., Petito, C. K., O'Hara, C. J., Groopman, J., Cho, E-S., Oleske, J. M., Wong-Staal, F., Gallo, R. C. (1985) HTLV-III infection of brains of children and adults with AIDS encephalopathy. Science 227, 177-182.
8. Lane, J. H., Sasseville, V. C., Smith, M. O., Vogel, P., Pauley, D. R., Heyes, M. P., Lackner, A. A. (1996) Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J. Neurovirol. 2, 423-432.
9. Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., Lackner, A. A. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427-431.
10. Kaul, M., Garden, G. A., Lipton, S. A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
11. Igarashi, T., Brown, C. R., Endo, A., Buckler-White, A., Plishka, R., Bischogberger, N., Hirsch, V., Martin, M. A. (2001) Macrophages are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. USA 98, 658-663.
12. Pelchen-Matthews, A., Kramer, B., Marsh, M. (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443-455.
13. Orenstein, J. M., Meltzer, M. S., Phipps, T., Gendelman, H. E. (1988) Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J. Virol. 62, 2578-2586.
14. Orenstein, J. M., Fox, C., Wahl, S. M. (1997) Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861.
15. Kennedy, D. W., Abkowitz, J. L. (1997) Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90, 986-993.
16. Lawson, L. J., Perry, V. H., Gordon, S. (1992) Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48, 405-415.
17. van Furth, R., Raeburn, J. A., van Zwet, T. L. (1979) Characteristics of human mononuclear phagocytes. Blood 54, 485-500.
18. Aquaro, S., Perno, C. F., Balestra, E., Balzarini, J., Cenci, A., Francesconi, M., Panti, S., Serra, F., Villani, N., Calio, R. (1997) Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. J. Leukoc. Biol. 62, 138-143.
19. Lambotte, O., Taoufik, Y., de Goer, M. G., Wallon, C., Goujard, C., Delfraissy, J. F. (2000) Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 23, 114-119.
20. Sonza, S., Mutime, H. P., Oelrichs, R., Jardine, D., Harvey, K., Dunne, A., Purcell, D. F., Birch, C., Crowe, S. M. (2001) Monocytes harbor replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 15, 17-22.
21. Zhu, T., Muthui, D., Holte, S., Nickle, D., Feng, F., Brodie, S., Hwangbo, Y., Mullins, J. I., Corey, L. (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14+ monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76, 707-716.
22. Bender, B. S., Davidson, B. L., Kline, R., Brown, C., Quinn, T. C. (1988) Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev. Infect. Dis. 10, 1142-1154.
23. Gendelman, H. E., Orenstein, J. M., Baca, L. M., Weiser, B., Burger, H., Kalter, D. C., Meltzer, M. S. (1989) The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3, 475-496.
24. Roy, S., Wainberg, M. A. (1988) Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS). J. Leukoc. Biol. 43, 91-97.
25. Spear, G. T., Kessler, H. A., Rothberg, L., Phair, J., Landay, A. L. (1990) Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals. Clin. Immunol. Immunopathol. 54, 184-191.
26. Swingler, S., Mann, A., Jacque, J-M., Brichacek, B., Sasseville, V. G., Williams, K., Lackner, A. A., Janoff, E. N., Wang, H., Fisher, D., Stevenson, M. (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5, 997-1003.
27. Ploegh, H. L., (1998) Viral strategies of immune evasion. Science 280, 248-253.
28. Collins, K., Chen, B., Kalams, S., Walker, B., Baltimore, D. (1998) HIV-1 Nef protein protects infected primary human cells from killing by cytotoxic T lymphocytes. Nature 391, 397-401.
29. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, K. J., McPhee, D. A., Greenway, A. L., Ellet, A., Chatfeld, C., Lawson, V. A., Crowe, S., Maerz, A., Sonza, S., Learment, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton, D., Mills, J. (1995) Genomic structure of an attenuated quasi species from a blood transfusion donor and recipients. Science 270, 988-991.
30. Kirchhoff, F., Geenough, T. C., Brettler, D. B., Sullivan, J. L., Desrosiers, R. C. (1995) Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232.
31. Learmont, J. C., Geczy, A. F., Mills, J., Ashton, L. J., Raynes-Greenow, C. H., Garsia, R., Dyer, W., McIntyre, L., Oelrichs, R. B., Rhodes, D. I., Deacon, N. J., Sullivan, J. S. (1999) Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N. Engl. J. Med. 340, 1715-1722.
32. Kestler, H. W. I., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., Desrosiers, R. C. (1991) Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell. 65, 651-662.
33. de Ronde, A., Klaver, B., Keulen, W., Smit, L., Goudsmit, J. (1992) Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes. Virology 188, 391-395.
34. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., Feinberg, M. B. (1994) The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
35. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelli, J. C., Richman, D. D. (1994) The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123.
36. Lundquist, C. A., Tobiume, M., Zhou, J., Unutmaz, D., Aiken, C. (2002) Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J. Virol. 76, 4625-4633.
37. Glushakova, S., Munch, J., Carl, S., Greenough, T. C., Sullivan, J. L., Margolis, L., Kirchhoff, F. (2001) CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4+ T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 75, 10113-10117.
38. Garcia, J. V., Miller, A. D. (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
39. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., Montagnier, L., Lecoeq, J. P. (1987) HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269.
40. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F., Heard, J. M. (1996) Endocytosis of MHC-I molecules is induced by HIV-1 Nef. Nat. Med. 2, 338-342.
41. Bell, I., Ashman, C., Maughan, J., Hooker, E., Cook, F., Reinhart, T. A. (1998) Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) ζ chain leads to TCR down-modulation. J. Gen. Virol. 79, 2717-2727.
42. Baur, A. S., Sass, G., Laffert, B., Willbold, D., Cheng, M. C., Peterlin, B. M. (1997) The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6, 283-291.
43. Collette, Y., Dutartre, H., Benziane, A., Ramos-Morales, F., Benarous, R., Harris, M., Olive, D. (1996) Physical and functional interaction of Nef with Lck. J. Biol. Chem. 271, 6333-6341.
44. Greenway, A., Azad, A., McPhee, D. A. (1995) Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842-1850.
45. Howe, A. Y., Jung, J. U., Desrosiers, R. C. (1998) ζ Chain of the T-cell receptor interacts wilh Nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J. Virol. 72, 9827-9834.
46. Lee, C-H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., Saksela, K. (1995) A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14, 5006-5015.
47. Nunn, M. F., Marsh, J. W. (1996) Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70, 6157-6161.
48. Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A., Cheng-Mayer, C. (1994) Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 1539-1543.
49. + viruses but not for down-regulation of CD4. EMBO J. 14, 484-491.
50. Smith, B. L., Krushelnycky, B. W., Mochly, R. D., Berg, P. (1996) The HIV Nef protein associates with protein kinase C θ. J. Biol. Chem. 271, 16753-16757.
51. Xu, X-N., Laffert, B., Screaton, G. R., Kraft, M., Wolf, D., Kolanus, W., Mongkolsapay, J., McMichael, A. J., Baur, A. S. (1999) Induction of fas ligand expression by HIV involves the interaction of Nef with the T cell receptor ζ chain. J. Exp. Med. 189, 1489-1496.
52. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J. S., Richman, D. D., Guateli, J. C. (1994) Optimal infectivity in vitro of human immunodeficiency virus type I requires an intact nef gene. J. Virol. 68, 2906-2914.
53. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B., Greene, W. C. (1995) Expression of human immunodeficiency virus type I (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp120 or viral entry. J. Virol. 69, 579-584.
54. Geleziunas, R., Xu, W., Tkeda, K., Ichijo, H., Greene, W. C. (2001) HIV-1 Nef inhibits ASKI-dependent death signaling providing a potential mechanism for protecting the infected host cell. Nature 410, 834-838.
55. Greenberg, M. F., Iafrate, A. J., Skowroriski, J. (1998) The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17, 2777-2789.
56. Le Gall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L., Benarous, R., Heard, J-M., Schwartz, O. (1998) Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495.
57. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., Baltimore, D. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671.
58. Williams, M., Roeth, J. F., Kasper, M. R., Fleis, R., Przybycin, C. G., Collins, K. (2002) Direct binding of human immunodeficiency virus type, 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplanmic tail disrupts MHC-I trafficking. J. Virol. 76, 12173-12184.
59. Piguet, V., Wan, L., Borel, C., Mangasarian, A., Demaurex, N., Thomas, G., Trono, D. (2000) HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2, 163-167.
60. Swann, S., Williams, M., Story, C., Bobbin, K., Fleis, R., Collins, K. (2001) HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI3-kinase-dependent pathway. Virology 282, 267-277.
61. Mangasarian, A., Piguet, V., Wang, J. K., Chen, Y., Trono, D. (1999) Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal α-helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73, 1964-1973.
62. Akari, H., Arold, S., Fukumori, T., Okazaki, T., Strebel, K., Adachi, A. (2000) Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74, 2907-2912.
63. Yamada, T., Kaji, N., Odawara, T., Chiba, J., Iwamoto, A., Kitamura, Y. (2003) Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J. Virol. 77, 1589-1594.
64. Munch, J., Stolte, N., Fuchs, D., Stahl-Hennig, C., Kirchhoff, F. (2001) Efficient class I major histocompatibility complex down-regulatron by simian immunodeficiency virus Nef is associated wrth a strong selective advantage in infected rhesus macaques. J. Virol. 75, 10532-10536.
65. Carl, S., Greenough, T. C., Krumbiegel, M., Greenberg, M., Skowronski, J., Sullivan, J. L., Kirchhoff, F. (2001) Modulation of different human immunodeficiency virus type I Nef functions during progression to AIDS. J. Virol. 75, 3657-3665.
66. Mahlknecht, U., Deng, C., Lu, M. C., Greenough, T. C., Sullivan, J. L., O'Brien, W. A., Herbein, G. (2000) Resistance to apoptosis in HIV-infected CD4+ T-lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence. J. Immunol. 165, 6437-6446.
67. Chen, B., Gandhi, R. T., Baltimore, D. (1996) CD4 down-modulation during infection of human T-cells with human immunodeficiency virus type I involves independent activities of vpu, env, and nef. J. Virol. 70, 6044-6053.
68. Cheng-Mayer, C., Quiroga, M., Tung, J. W., Dina, O., Levy, J. A. (1990) Viral determinants of human immunodeficiency virus type 1 T-cell and macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64, 4390-4398.
69. Brown, A., Moghaddam, S., Kawano, T., Cheng-Mayer, C. (2004) Multiple human immunodeficiency virus type I Nef functions contribute to efficient replication in primary human macrophages. J. Gen. Virol. 85, 1463-1469.
70. Brown, A., Wang, X., Sawai, F., Cheng-Mayer, C. (1999) Activation of the PAK-related kinase by human immunodefeciency virus type I Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J. Virol. 73, 9899-9907.
71. Gartner, S. (1990) Virus isolation and production. In Techniques in HIV Research (A. Aldovini, B. Walker, eds.), Oxford, UK, Oxford University Press.
72. Wiskerchen, M., Cheng-Mayer, C. (1996) HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 224, 292-301.
73. Rich, E. A., Orenstein, J. M., Jeang, K-T. (2002) A macrophage-tropic HIV-1 that expresses green fluorescent protein and infects alveolar and blood monocyte-derived macrophages. J. Biomed. Sci. 9, 721-726.
74. Herbein, G., Van Lint, C., Lovett, J. L., Vertun, E. (1998) Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and uninfecled bystander T lymphocytes. J. Virol. 72, 660-670.
75. Muller, B., Daecke, J., Fackler, O. T., Dittmar, M. T., Zentgraf, H., Krausslich, H-G. (2004) Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78, 10803-10813.
76. Jamieson, B. D., Zack, J. A. (1998) In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72, 6520-6526.
77. Balliet, J. W., Kolson, D. L., Eiger, G., Kim, F. M., McGann, K. A., Srinivasan, A., Collman, R. (1994) Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200, 623-631.
78. Haltori, N., Michaels, F., Fargnoli, K., Marcon, L., Gallo, R. C., Franchini, G. (1990) The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA 87, 8080-8084.
79. Connor, R. I., Chen, B. K., Choe, S., Landau, N. R. (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935-944.
80. Campbell, B., Hirsch, V. M. (1997) Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes. J. Virol. 71, 5593-5602.
81. Hua, J., Cullen, B. R. (1997) Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sistes for clownregulation of cell surface CD4. J. Virol. 71, 6742-6748.
82. Grzesiek, S., Stahl, S. J., Wingfield, P. T., Bax, A. (1996) The CD4 determinant for dowurcgulation by HIV-1 Nef directly binds to Nef: mapping of the Nef-binding surface by NMR. Biochemistry 35, 10256-10261.
83. Crise, B., Buonocore, L., Rose, J. K. (1990) CD4 is retained in the endoplasmic reticuhim by human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64, 5585-5593.
84. Willey, R. L., Maldarelli, F., Martin, M. A., Strebel, K. (1992) Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.
85. Liu, X., Schrager, J. A., Lange, G. D., Marsh, J. W. (2001) HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. 276, 32763-32770.
86. Triques, K., Stevenson, M. (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J. Virol. 78, 5523-5527.
87. Schuitemaker, H., Kootstra, N. A., Fouchier, R. A., Hooibrink, B., Miedema, F. (1994) Productive HIV-1 infection of macrophages is restricted to the cell fraction with proliferative capacity. EMBO J. 13, 5929-5936.
88. Eisert, V., Kreutz, M., Becker, K., Konigs, C., Alex, U., Rubsamen-Waigmann, H., Audreesen, R., von Briesen, H. (2001) Analysis of cellular factors influencing the replication of human immunodeficiency virus type 1 in human macrophages derived from blood of different healthy donors. Virology 286, 31-44.
89. Lee, B., Sharron, M., Montaner, L. J., Weissman, D., Doms, R. W. (1999) Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 96, 5215-5220.
90. Sonza, S., Maerz, A., Deacon, N. J., Meanger, J., Mills, J., Crowe, S. M. (1996) Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated pheripheral blood monocytes. J. Virol. 70, 3863-3869.
91. Pantaleo, G., Koup, R. A. (2004) Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 10, 806-810.
92. Baldwin, G. C., Fleischmann, J., Chung, Y., Koyanagi, Y., Chen, I. S., Golde, D. W. (1990) Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. USA 87, 3933-3937.
93. Ennen, J., Seipp, I., Norley, S. G., Kurth, R. (1990) Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro. Eur. J. Immunol. 20, 2451-2456.
94. Prince, H. E., Moody, D. J., Shubin, B. I., Fahey, J. L. (1985) Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system. J. Clin. Immunol. 5, 21-25.
95. Rich, E. A., Toossi, Z., Fujiwara, H., Hanigosky, R., Lederman, M. M., Ellner, J. J. (1988) Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. J. Lab. Clin. Med. 112, 174-181.
96. Mann, D. L., Gartner, S., Le Sane, F., Buchow, H., Popovic, M. (1990) HIV-1 transmission and function of virus-infected monocytes/macrophages. J. Immunol. 144, 2152-2158.
97. Lopez de Castro, J. A. (1989) HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol. Today 10, 239-246.
98. Trachtenberg, E., Korber, B., Sollars, C., Kepler, T. B., Hraber, P. T., Hayes, E., Funkhouser, R., Fugate, M., Theiler, J., Hsu, Y. S., Kunstman, K., Wu, S., Phair, J., Erlich, H., Wolinsky, S. (2003) Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9, 928-935.
99. Yang, O. O., Sarkis Nguyen, P., Ali, A., Harlow, J. D., Brander, C., Kalams, S. A., Walker, B. D. (2003) Determinants of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 197, 1365-1375.